PROFICIA

Development of a proprietary recombinant protein platform technologies designed to lead to new pharmaceutical products namely-- vaccines, antibiotics, antiviral, anti-inflammatory, anti-infectives, anti-fungals, antiprurities, cardiovascular agents, hormones, antineoplastics, anti-cancer, antipsychotics, anti-anginals, anti-thrombotics, anti-arrhythmia and anti-hypertensives